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Effects of Isometric Handgrip Training in Patients With Peripheral
Artery Disease: A Randomized Controlled Trial
Marilia A. Correia, PhD; Paulo L. Oliveira, MS; Breno Q. Farah, PhD; Lauro C. Vianna, PhD; Nelson Wolosker, MD, PhD;
Pedro Puech-Leao, MD, PhD; Daniel J. Green, PhD; Gabriel G. Cucato, PhD; Raphael M. Ritti-Dias, PhD
Background-—Meta-analyses have shown that isometric handgrip training (IHT) can reduce brachial systolic and diastolic blood
pressure (BP) by >6/4 mm Hg, respectively. However, whether IHT promotes these effects among patients with peripheral artery
disease, who exhibit severe impairment in cardiovascular function, is currently unknown. This study aimed to evaluate the effects
of IHT on the cardiovascular function of patients with peripheral artery disease.
Methods and Results-—A randomized controlled trial with peripheral artery disease patients assigned to either the IHT or control
group was conducted. The IHT group performed 3 sessions per week, for 8 weeks, of unilateral handgrip exercises, consisting of 4
sets of isometric contractions for 2 minutes at 30% of maximum voluntary contraction and a 4-minute interval between sets. The
control group received a compression ball in order to minimize the placebo effects, representing sham training. The primary
outcome was brachial BP. The secondary outcomes were central BP, arterial stiffness parameters, cardiac autonomic modulation,
and vascular function. The IHT program reduced diastolic BP (75 [10] mm Hg preintervention versus 72 [11] mm Hg
postintervention), with no change in the control group (74 [11] mm Hg preintervention versus 74 [11] mm Hg postintervention),
with this between-group difference being signiﬁcant (P=0.04). Flow-mediated dilation improved in the IHT group (6.0% [5.7]
preintervention versus 9.7% [5.5] postintervention), with no change in the control group (7.6% [5.5] preintervention versus 7.4%
[5.1] postintervention), with this between-group difference being signiﬁcant (P=0.04). There was no change in other measured
variables over the intervention period.
Conclusions-—IHT reduced brachial diastolic BP and improved local vascular function in patients with peripheral artery disease.
Clinical Trial Registration-—URL: https://www.clinicaltrials.gov/. Unique identiﬁer: NCT02742220. ( J Am Heart Assoc. 2020;9:
e013596. DOI: 10.1161/JAHA.119.013596.)
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P atients with peripheral artery disease (PAD) oftenpresent with multiple health comorbidities, such as
hypertension, diabetes mellitus, and dyslipidemia,1 and are at
an increased risk for fatal and non-fatal cardiovascular
events.2,3 Interventions to manage and reduce cardiovascular
disease, and its complications, are therefore highly recom-
mended for patients with PAD.4
A supervised walking program has been recommended as
a ﬁrst-line strategy for patients with PAD to enhance walking
capacity and cardiovascular function.5–7 However, claudica-
tion symptoms are a barrier to physical activity in these
patients.8 Moreover, traveling to an exercise center for
supervised exercise training can be burdensome, with many
patients declining participation in center-based exercise
rehabilitation.9 In addition, a home-based exercise program
was recently recommended as exercise therapy for PAD by
the American Heart Association (level of evidence, A; class of
recommendation, IIA).10 Therefore, a home-based program of
exercise, using nonpainful modalities, could provide a suitable
alternative strategy for patients with PAD.
Previous meta-analyses11–14 have shown that isometric
handgrip training (IHT) can reduce brachial systolic and diastolic
blood pressure (BP) by >6/4 mm Hg in normotensive,
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prehypertensive, and hypertensive patients.12,15 In addition,
improvements in cardiac autonomic function,16,17 arterial
stiffness,18 and local endothelial function19,20 have been also
been reported after IHT,17,19–21 although these are not universal
ﬁndings.22 Furthermore, all studies were conducted in normo-
and hypertensive subjects, and whether IHT promotes effects
on cardiovascular system in patients with PAD, who exhibit
more impaired cardiovascular function than hypertensives, is
currently unknown.
The aim of our study was to evaluate the effects of IHT on
the cardiovascular function of patients with PAD. Our
hypothesis was that IHT would decrease BP, with concomitant
improvement in vascular function and/or autonomic cardiac
modulation (measured by heart rate variability) in patients
with PAD. These changes could modify the indicators of
arterial stiffness.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
Trial Design
This randomized controlled trial study, using 2 parallel groups,
was preregistered in the www.clinicaltrials.gov database
under the registration number NCT02742220 and is part of
the ISOPRESS network.23 The procedures of our trial were
approved by the institutional review board, in compliance with
the Brazilian National Research Ethics System Guidelines.
Written informed consent was obtained from each patient
before participation in any phase of the study. This study
follows the CONSORT (Consolidated Standards of Reporting
Trials) checklist.24
Participants
Patients with PAD were recruited from hospitals in S~ao Paulo,
Brazil between March 2016 and January 2018. The inclusion
criteria were: (1) age ≥45 years; (2) presence of PAD stage IIa
and IIb, based on the Rutherford criteria; (3) an ankle-brachial
index <0.90; (4) for women, being postmenopausal without
hormone therapy replacement; (5) absence of critical limb
ischemia, pain at rest, amputated limbs, and/or ulcers; (6)
absence of neurological and/or cognitive diseases; and; (7)
having the capacity to perform a home-based program of
exercise. Patients who did not adhere to at least 80% of the
prescribed training session, changed the type and/or dose of
their antihypertensive medication, or presented with any health
problems that contraindicated physical activity were excluded.
Screening
Sociodemographic information, comorbidities, and medication
information were obtained through a face-to-face interview.
Sociodemographic variables included age and sex (male or
female). The clinical history included: smoking habit (ex- or
current- or never-smoker), obesity (body mass index≥30 kg/
m²), diabetes mellitus (doctor-diagnosed or use of glucose-
lowering drugs), hypertension (systolic/diastolic BP ≥140/
90 mm Hg or use of antihypertensive drugs), dyslipidemia
(doctor-diagnosed or use of lipid-lowering drugs), coronary
heart disease, heart failure, and cerebrovascular disease
(medical history). Body weight was measured using a
calibrated scale, to the nearest 0.1 kg, with height measured
using a stadiometer, to the nearest 0.01 m. The body mass
index (kg/m2) was calculated from these values.
PAD severity was determined by a single evaluator using the
ankle-brachial index, in accord with previous guideline.25
Brieﬂy, the ankle-brachial index was measured as the highest
systolic BP in the posterior tibial or dorsalis pedis artery divided
by the highest systolic BP in the brachial artery. BP measure-
ments were recorded in both limbs using a Doppler vascular
monitor (Medmega DV160; Medmega Industria Equipamentos
Medico, Franca, Brazil) and a sphygmomanometer.
Randomization and Allocation
Participants were randomly assigned to either the IHT group or
the control group (CG), using a block randomization number
Clinical Perspective
What Is New?
• This is the ﬁrst study to analyze the effect of isometric
handgrip training on cardiovascular function of peripheral
artery disease patients.
• This modality of training improves cardiovascular function of
normotensive, prehypertensive, and hypertensive patients;
however, until the present study, the effect of isometric
handgrip training in peripheral artery disease patients, who
exhibit severe impairment in cardiovascular function, was
unknown.
• This randomized controlled trial concluded that isometric
handgrip training reduced brachial diastolic blood pressure
and improved local vascular function in patients with
peripheral artery disease.
What Are the Clinical Implications?
• Isometric handgrip training, which is a simple and home-
based modality of training, can be an adjunct strategy only
to reduce brachial diastolic blood pressure in patients with
peripheral artery disease.
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table, with numbers generated by www.randomizer.org, strat-
iﬁed by sex and baseline brachial systolic BP. This randomiza-
tion was done by a researcher not involved directly in the
recruitment and data collection. Allocation was concealed to
the researchers and patients involved in the study.
Interventions
After screening, a familiarization of the session with the
program to be performed at home was conducted to ensure
understanding and comfort with the program. During this
session, patients’ questions and any difﬁculties with perfor-
mance of the program were addressed.
The IHT group performed 3 sessions per week, for 8 weeks,
at home, guided by an experienced kinesiologist, who previ-
ously familiarized the patients with the exercise protocol and
encouraged the patients by telephone to continue IHT training.
The exercise protocol consisted of 4 sets of 2-minute isometric
handgrip holds unilateral (dominant arm), performed at 30% of
maximum vonluntary contraction with a 4-minute rest interval
between repetitions. All patients used the Zona Plus (Zona
Health, Inc, a Boise, ID) isometric handgrip device, which
provided instructive text prompts, on a liquid crystal display, for
each step of the training session, as well as visual (liquid crystal
display pressure gauge) and audible signals for feedback to
ensure compliance with the exercise intensity of the protocol.
Adherence to the programwas deﬁned as completion of at least
80% of the prescribed training session, with >96 seconds of
isometric contraction held for each repetition in each session,
exported from Zona Plus at the end of the training. Patients
randomized to the CG received a compression ball in order to
minimize the manipulation effect of a device and the placebo
effects, thus representing sham training. It was recommended
that the patients perform 3 sessions per week, with 3 sets of 10
compressions, for each hand, with a 1-minute rest interval
between sets.
Patients in both groups were instructed to increase their
general daily physical activity level to meet the recommen-
dations for PAD patients, namely, 150 minutes of moderate
physical activity or 75 minutes of vigorous physical activities,
or an equivalent combination of moderate-to-vigorous phys-
ical activities per week. Patients also received a diary to
record the sessions and report difﬁculties during training. A
visit was scheduled at the ﬁfth week to provide feedback and
discuss possible problems during the training. In addition,
once every 2 weeks, each patient was contacted by phone to
reinforce exercise recommendations.
Outcomes
The primary outcome of the study was brachial BP. Secondary
outcomes were: (1) central BP; (2) arterial stiffness
parameters; (3) cardiac autonomic modulation; (4) vascular
function; and (5) physical activity. All parameters were
analyzed at baseline and after 8 weeks of an intervention
period.
Before all cardiovascular measurements, patients were
instructed to: eat a light meal before arriving at the laboratory;
avoid moderate-to-vigorous physical activity for at least
24 hours before the visit; and avoid smoking, alcohol, and
caffeine ingestion for at least 12 hours. In the laboratory, a
rest period of 10 minutes in the supine position before the
measures was given. All cardiovascular measurements were
taken between 7:00 AM to 6:00 PM, in the supine position in a
quiet environment, with monitored temperature, and no
interruptions. The time of the day of the preintervention
measurements of each subject was maintained in postinter-
vention evaluations.
Brachial BP (primary outcome)
Brachial BP was measured through an oscillometric device
(HEM 742; Omron Healthcare, Kyoto, Japan). Three consec-
utive measurements were performed at a 1-minute interval, in
both arms, with the proper cuff size to arm circumference.
The value used was the average of the 3 measures of the
highest BP arm.26
Central BP (secondary outcome)
Central BP was obtained by pulse-wave analysis, recorded in
the radial artery, using applanation tonometry (SphygmoCor;
AtCor Medical, Sydney, Australia). The validated transfer
function algorithm provided by the Sphygmocor software
obtained the central values of systolic and diastolic BP
(equivalent to the pressure wave measured by an invasive
catheter).27 To enhance the accuracy of measurements, only
those values whose quality index exceeded 90% were utilized.
The value used was of the highest BP arm.
Arterial stiffness parameters (secondary outcome)
Pulse pressure (difference between systolic and diastolic BP)
and augmentation index (the proportion of pulse pressure that
is attributed to the reﬂected pulse wave) were obtained
through applanation tonometry (SphygmoCor; AtCor Medical)
in the radial artery in both arms, being used to analyze the
highest BP arm. Carotid-femoral pulse wave velocity was
measured by applanation tonometry (Sphygmocor; AtCor
Medical), following the guidelines of the Clinical Application of
Arterial Stiffness, Task Force III.28 Distances between carotid
artery to the suprasternal notch and femoral artery to the
suprasternal notch were measured using a standard tape.
Simultaneous ECG was assessed to obtain heart rate, and,
according to a “foot-to-foot” method, the time difference
between the points was measured. Then, the distance
between the 2 arteries was divided by the time difference.
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 3
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Cardiac autonomic modulation (secondary outcome)
Cardiac autonomic modulation was assessed though heart
rate variability from the RR intervals obtained by a heart rate
monitor (RS800CX; Polar Electro, Espoo, Finland). Patients
remained in the supine position for 10 minutes and were
stationary for at least 5 minutes; we analyzed these station-
ary 5 minutes period. All analyses were performed using
software (Kubios HRV; Biosignal Analysis and Medical Imaging
Group, University of Eastern Finland, Kuopio, Finland) by a
single evaluator blinded to the group allocations, using the
recommendations of the Task Force for heart rate variability
(Task Force of the European Society of Cardiology and the
North American Society of Pacing and Electrophysiology).29
The following time-domain variables were examined for each
recording: standard deviation of all RR intervals, root mean
square of the squared differences between adjacent normal
RR intervals, and the percentage of number of pairs of
adjacent NN intervals differing by more than 50 ms. Addi-
tionally, frequency-domain variables were calculated by an
autoregressive method. The signals operating at frequencies
between 0.04 and 0.4 Hz were considered physiologically
signiﬁcant with the low-frequency component represented by
oscillations between 0.04 and 0.15 Hz and the high-frequency
component represented by oscillations between 0.15 and
0.4 Hz. The power of each spectral component was normal-
ized by dividing the power of each spectrum band by the total
variance, minus the value of the very-low-frequency band
(<0.04 Hz) and multiplying the result by 100. To interpret the
results, the low- and high-frequency normalized components
were considered, respectively, as representative of predom-
inantly combined parasympathetic-sympathetic and parasym-
pathetic modulation of the heart, and the ratio between these
bands was deﬁned as the cardiac sympathovagal balance.
Vascular function (secondary outcome)
Blood ﬂow and ﬂow-mediated dilation measurements were
obtained by ultrasound according to the global recommenda-
tions.30 Images of the brachial artery of trained and
nontrained arms were recorded by a 2-dimensional ultrasound
machine with spectral Doppler and linear transducer (Ultra-
0122; Philips, Best, The Netherlands). The contrast resolution,
depth, and gain were adjusted to optimize the longitudinal
images of the lumen/arterial wall interface. Brachial artery
diameter and insonation angle corrected at 60 degrees blood
velocity spectra were simultaneously recorded by the pulsed-
wave mode at linear frequencies of 10 and 6.0 MHz,
respectively. Baseline diameter and blood velocity waveforms
were continuously recorded over 120 seconds. After that, a
cuff, placed on the forearm, was inﬂated to a pressure
>50 mm Hg above systolic BP, measured before the exam-
ination. The occlusion was maintained for 5 minutes and,
after this period, rapidly released. The recordings were
resumed 30 seconds before deﬂation and maintained for
180 seconds after. The diameter of brachial artery and
postocclusion blood ﬂow velocity were measured after the
release.
All vascular variables were analyzed ofﬂine using special-
ized edge-detection software (Cardiovascular Suite; Quipu,
Pisa, Italy). Flow-mediated dilation was calculated by the
percentage of increase in diameter of the brachial artery
postocclusion compared with their baseline values. The
anterograde component of blood ﬂow was deﬁned as the
area above and below 0 cm/s on the horizontal axis of the
Doppler. The area under the shear rate curve, indicative of the
vasodilation stimulus, was calculated from the moment the
cuff was released until the maximum diameter was reached.
Blood ﬂow was calculated from the formula: blood ﬂow=p
(0.59D)29Vm, where Vm corresponds to the mean velocity of
blood ﬂow in centimeters per second, and D represents the
diameter of the brachial artery.
Physical activity (secondary outcome)
Physical activity was obtained in a subgroup of the sample
(IHT=25 and CG=25) through a 3-dimensional accelerometry
monitor (A300; Polar Electro), which gets patients’ steps each
day of use. This monitor was used 1 week before intervention
and in the last week of the intervention. The average number
of steps during the days of using before and after intervention
was considered.
Statistical Analysis
The data were stored and analyzed using the Statistical
Package for the Social Sciences (SPSS Version 20.0; SPSS,
Inc, Chicago, IL). Normality and homogeneity were checked
using Shapiro–Wilk’s and Levene’s tests, respectively. Con-
tinuous variables were summarized as mean and SD (normally
distributed data) or median and interquartile range (non-
normally distributed data), whereas categorical variables were
summarized as relative frequencies. Clinical and cardiovas-
cular baseline characteristics were compared using Mann–
Whitney U tests for continuous variables and the chi-square
test for categorical variables.
To compare the effects of interventions (IHT or CG) on
cardiovascular parameters, generalized estimating equa-
tions were used, followed by a post hoc pair-wise
comparison using the Bonferroni correction for multiple
comparisons. When there was a signiﬁcant difference
between groups in preintervention variables (low fre-
quency/high frequency ratio), preintervention values were
used as adjustments.
Per-protocol analyses were conducted in patients who
adhered to at least 80% of the prescribed training session, did
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 4
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not changed the type and/or dose of their medications, and
did not present with any health problems that contraindicated
physical activity.
Intention-to-treat analysis was used to estimate overall
effects, with all randomized patients ignoring noncompli-
ance and dropouts. In order to do that, multiple
Figure 1. Flowchart of study. PAD indicates peripheral artery disease.
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 5
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imputations with linear regression weighted by group were
applied.
The signiﬁcance level was set at P<0.05 for all analyses.
Results
Recruitment and intervention periods were completed
between January 2015 and December 2018. The study
ﬂowchart is shown in Figure 1. Of the 277 patients screened
for possible inclusion, 129 were considered eligible, with 102
of these ultimately entered into the trial, with 50 randomized
to the IHT group and 52 to the CG group. The data from all
these patients were included in the intent-to-treat analysis.
Because of multiple disease comorbidities and technical
problems with the ultrasound device, some variables were not
obtained, as detailed in Figure 1.
Baseline clinical characteristics were not different between
the 2 groups (Table 1). Cardiovascular parameters (Table 2)
were also comparable between the 2 groups in the preinter-
vention period, with the exception of the frequency domain of
heart rate variability, with patients in the IHT group presenting
higher sympathovagal balance (low frequency/high fre-
quency, P=0.041), compared with those in the CG group.
Of the 50 patients randomized to the IHT group, 74%
completed training sessions weekly, with 58% training at the
appropriate intensity. Therefore, of the50 patients included in the
IHTgroup,29completed theprotocol asprescribedand thuswere
included in the per-protocol analysis (Table 3; Figures 2 and 3).
Table 1. Characteristics of Peripheral Artery Disease Patients Included in the Sample n=102
Variables Control Group (n=52) IHT (n=50) P Value
Sex, % men 62 66 0.684
Age, y 67 (11) 66 (12) 0.207
Body mass index, kg/m2 26 (7) 27 (5) 0.510
Ankle brachial index 0.60 (0.24) 0.57 (0.22) 0.318
Intima-medial thickness, mm 0.098 (0.038) 0.089 (0.033) 0.406
Risk factors
Diabetes mellitus, % 47 41 0.554
Hypertension, % 79 79 0.958
Dyslipidemia, % 89 89 >0.999
Obesity, % 27 20 0.410
Coronary artery disease, % 32 35 0.773
Medication
Antiplatelet, % 84 83 0.813
Inhibitor of ACE, % 31 26 0.596
Angiotensin-receptor antagonist, % 31 26 0.596
Calcium-channel blocker, % 24 37 0.196
Diuretic, % 36 41 0.573
Beta-blockers, % 38 52 0.168
Statins, % 93 87 0.485
Hypoglycemics, % 55 37 0.094
Peripheral vasodilator, % 33 20 0.136
Physical capacity
Claudication onset distance, m 117 (106) 120 (96) 0.598
Six-minute walk distance, m 250 (356) 302 (290) 0.167
Steps per day* 5704 (3617) 5196 (2678) 0.575
Handgrip strength, kgf 30.0 (14.8) 33.0 (12.5) 0.736
Data presented as mean (standard deviation) or relative frequency. P, level of signiﬁcance in independent t test. ACE indicates angiotensin-converting enzyme; CG, control group; IHT,
isometric handgrip training group.
*Data from a subgroup analysis of 25 patients in IHT and 25 patients in the CG.
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 6
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There was no effect of IHT in brachial systolic BP (142
[21] mm Hg preintervention versus 136 [23] mm Hg
postintervention), when compared with CG (149 [23] mm Hg
preintervention versus 146 [22] mm Hg postintervention;
P=0.384). The IHT program reduced brachial diastolic BP (75
[10] mm Hg preintervention versus 72 [11] mm Hg postin-
tervention), with no change in the CG (74 [11] mm Hg
preintervention versus 74 [11] mm Hg postintervention),
with this between-group difference being signiﬁcant
(P=0.047). Central systolic and diastolic BP did not change,
with a signiﬁcance of interaction of P=0.544 and P=0.086,
respectively.
Flow-mediated dilation of the trained arm increased in the
IHT group (6.0% [5.7] preintervention versus 9.7% [5.5]
postintervention), with no change in the control group (7.6%
[5.5] preintervention versus 7.4% [5.1] postintervention], with
this between-group difference being signiﬁcant (P=0.042).
When analyzing data from both arms (number of patients,
IHT=17 and CG=25; Figure 3), it was observed that the
untrained arm did not improve ﬂow-mediated dilation
Table 2. Cardiovascular Parameters of Patients With Peripheral Artery Disease Patients in Preintervention Moment
Variables n Control Group n IHT P Value
Blood pressure
Brachial systolic BP, mm Hg 52 149 (23) 50 143 (22) 0.189
Brachial diastolic BP, mm Hg 52 75 (11) 50 74 (10) 0.768
Central systolic BP, mm Hg 51 137 (23) 47 133 (21) 0.317
Central diastolic BP, mm Hg 51 75 (11) 47 75 (10) 0.998
Heart rate variability
RR interval, ms 49 931 (164) 44 949 (179) 0.779
SDNN, ms* 49 30.3 (23.5) 44 25.9 (29.0) 0.572
RMSSD, ms* 49 23.3 (24.0) 44 15.2 (25.2) 0.120
pNN50, %* 49 2.9 (12.8) 44 0.65 (7.6) 0.084
Low frequency, ms2* 49 214 (316) 44 137 (434) 0.770
High frequency, ms2* 49 180 (302) 44 74 (220) 0.245
LF/HF* 49 0.94 (1.32) 44 1.44 (2.67) 0.041
SD1, ms* 49 16.5 (17.1) 44 10.8 (17.8) 0.124
SD2, ms* 49 39.6 (29.9) 44 34.4 (36.5) 0.794
Shannon entropy* 49 3.21 (0.71) 44 3.23 (0.47) 0.908
Sample entropy* 49 1.44 (0.72) 44 1.42 (0.45) 0.703
Vascular mechanisms
Brachial pulse pressure, mm Hg* 52 76 (25) 50 66 (24) 0.156
Pulse pressure, mm Hg* 51 62 (25) 47 54 (19) 0.174
Augmentation index, % 51 38 (10) 47 36 (12) 0.392
Pulse wave velocity, m/s 41 9.4 (2.6) 43 9.7 (2.7) 0.570
Brachial diameter, mm 34 3.97 (0.57) 36 4.01 (0.73) 0.764
Flow-mediated dilation, %* 33 5.7 (7.5) 35 4.9 (6.3) 0.267
Flow-mediated dilation, mm* 33 0.25 (0.29) 35 0.20 (0.22) 0.195
Time to maximum diameter, s* 33 63 (81) 35 55 (55) 0.535
AUC shear rate91001* 32 172 (135) 34 172 (84) 0.700
Blood flow, mL/min* 34 65 (35) 36 68 (47) 0.240
FMD/AUC91001* 32 0.05 (0.06) 34 0.03 (0.03) 0.132
Data presented as mean (SD). P, level of signiﬁcance in independent t test or Mann–Whitney U tests. AUC indicates area under the curve of shear rate; BP, blood pressure; FMD/AUC, ﬂow-
mediated dilation corrected by area under the curve of shear rate; IHT, isometric handgrip group; LF/HF, low frequency/high frequency ratio; pNN50, percentage of number of pairs of
adjacent NN intervals differing by more than 50 ms; RMMSD, root mean square of the squared differences between adjacent normal RR intervals; SDNN, standard deviation of all RR
intervals.
*Data presented as median (interquartile range).
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 7
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(P>0.123). There was no change in other measured variables
over the intervention period.
No change in general physical activity level was
observed in either group over the 8-week period of
observation (P=0.509): IHT group, 5196 (2678)
steps preintervention versus 6079 (3133) steps
postintervention; and CG group, 5703 (3617)
steps preintervention versus 5909 (3619) steps postin-
tervention.
The intent-to-treat analysis (Table 4) did not reveal a
signiﬁcant effect of the IHT program on any of the measured
outcome variables.
Table 3. Effects of IHT in Cardiovascular Parameters in Peripheral Artery Disease Patients
Variables
Control Group (n=50) IHT (n=29)
Interaction
Effectn Pre Post n Pre Post
Blood pressure
Brachial SBP, mm Hg 50 149 (23) 146 (22) 29 142 (21) 136 (23) 0.384
Brachial DBP, mm Hg 50 74 (11) 74 (11) 29 75 (10) 72 (11)† 0.047‡
Central SBP, mm Hg 46 138 (23) 135 (21) 27 133 (21) 127 (24) 0.544
Central DBP, mm Hg 46 75 (11) 75 (11) 27 76 (11) 73 (11) 0.086
Heart rate variability
RR interval, ms* 45 880 (244) 893 (238) 25 896 (241) 929 (194) 0.929
SDNN, ms* 45 30.3 (23.5) 29.5 (23.1) 25 29.4 (30.8) 40.3 (38.2) 0.212
RMSSD, ms* 45 23.3 (24) 18.9 (26.6) 25 15.1 (33) 23.0 (27.8) 0.461
pNN50, %* 45 2.9 (12.8) 2.1 (13.3) 25 1.6 (14.3) 3.2 (16.3) 0.584
Low frequency, ms2 45 214 (316) 159 (482) 25 257 (561) 303 (734) 0.264
High frequency, ms2 45 180 (302) 137 (412) 25 74 (504) 136 (591) 0.828
LF/HF 45 1.64 (2.08) 2.04 (3.21) 25 2.54 (2.18) 3.08 (3.87) 0.964
SD1, ms* 45 16.5 (27.9) 13.4 (18.8) 25 21.4 (10.7) 16.3 (19.6) 0.463
SD2, ms* 45 39.6 (29.9) 39.6 (31.8) 25 38.3 (38.9) 51.1 (47.9) 0.477
Shannon entropy* 45 3.21 (0.71) 3.12 (0.49) 25 3.33 (0.52) 3.17 (0.41) 0.769




50 75 (19) 72 (20) 29 67 (16) 65 (17) 0.389
Central pulse pressure,
mm Hg *
46 62 (25) 58 (26) 27 55 (22) 53 (24) 0.487
Augmentation index, % 46 38 (10) 36 (9) 27 35 (12) 35 (10) 0.217
Pulse wave velocity, m/s 37 9.6 (2.5) 9.2 (2.7) 26 9.3 (2.8) 9.6 (2.8) 0.251
Brachial diameter, mm 31 4.02 (0.48) 4.15 (0.50) 19 4.00 (0.62) 4.11 (0.63) 0.507
Flow-mediated dilation, % 31 7.4 (4.8) 7.7 (5.2) 19 5.3 (5.2) 9.1 (5.1)† 0.042‡
Flow-mediated dilation, mm* 31 0.25 (0.28) 0.26 (0.32) 19 0.15 (0.20) 0.31 (0.32) 0.042‡
Time to maximum diameter, s 31 82 (46) 98 (43) 19 64 (39) 93 (35) 0.568
AUC shear rate91001* 31 176 (135) 203 (139) 19 168 (91) 146 (130) 0.913
FMD/AUC 31 0.05 (0.05) 0.06 (0.05) 19 0.03 (0.04) 0.08 (0.05) 0.069
Blood flow 31 69 (27) 80 (40) 19 77 (34) 66 (43) 0.173
Parametric data presented as mean (SD). AUC indicates area under the curve of shear rate; DBP, diastolic blood pressure; FMD/AUC, ﬂow-mediated dilation corrected by area under the
curve of shear rate; IHT, isometric handgrip group; LF/HF, low frequency/high frequency ratio; n, number of data for each variable analyzed; pNN50, percentage of number of pairs of
adjacent NN intervals differing by more than 50 ms; RMMSD, root mean square of the squared differences between adjacent normal RR intervals; SBP, systolic blood pressure; SDNN,
standard deviation of all RR intervals.
*Nonparametric data presented as median (interquartile range).
†Different from preintervention.
‡Interaction effect signiﬁcant P<0.05.
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Discussion
Our study is the ﬁrst to analyze the effects of IHT on
cardiovascular function in patients with PAD, and our main
ﬁnding were that 8 week of home-based program of HIT
decrease brachial diastolic BP and improves vascular function
in patients with PAD. However, there was no effect of IHT on
systolic brachial BP, systolic and diastolic central BP, heart
rate variability, or arterial stiffness parameters.
A previous study among normotensive, prehypertensive,
and hypertensive individuals reported a reduction in brachial
systolic BP >6 mm Hg after IHT.12 Our results were not
consistent with these previous ﬁndings, in which our IHT
program did not reduce brachial or central systolic BP in
patients with PAD. Given that our exercise protocol and
program duration were similar to a previously described
program using IHT, patient-speciﬁc factors provided a plau-
sible explanation for the lack of reductions in systolic BP.
Compared with previous research reporting a decrease in
systolic BP with IHT,15 patients in our study were older,
presented more comorbidities, used more types of medica-
tions, and presented with more-advanced cardiovascular
disease. Of note, a previous study similarly reported absence
of an improvement in systolic BP with a program of dynamic
resistance training in patients with PAD,31 indicating possible
limitations of resistance training for altering systolic BP in this
clinical population.
Among the autonomic and vascular parameters analyzed,
only local ﬂow-mediated dilation was improved after the 8-
week IHT program. The absence of change in cardiac
autonomic modulation and arterial stiffness with resistance
training may reﬂect the severity of abnormality in cardiac
autonomic control32,33 and arterial stiffness34 in patients with
PAD. The improvement in vascular function that was observed
in the trained limb may have been mediated by the ischemia-
Figure 2. Brachial systolic (A) and diastolic (B) blood pressure responses, before and after the 8-week isometric handgrip training (IHT) and
the 8 weeks of sham training in the control group. *Different from preintervention moment.
Figure 3. Flow-mediated dilation in (A) trained arm and (B) nontrained arm, before (black bar) and after
(white bar) 8 weeks of isometric handgrip training (IHT) and the 8 weeks of the sham training in control
group.
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reperfusion phenomenon, leading to activation of a cascade of
events that ultimately promote vasodilation. Given that these
effects occur only in the exercised muscles, improvement in
vascular function in the trained limb might be expected, as
previously reported in hypertensive patients who completed a
program of uni- or bilateral IHT.20 This raises the possible
relevance of lower-limb isometric exercise, involving larger
muscle groups, as a possible intervention to promote
adaptation in vascular function and possibly lowering BP.
Our 8-week program of IHT yielded a decrease in diastolic
BP of 3.4 mm Hg, on average, which is slightly lower than the
previously reported range of 4 to 8 mm Hg after IHT.12,13
Although the improvements in local ﬂow-mediated dilation
after IHT might be related to this response, it is unlikely that
this local unilateral upper-limb adaptation was responsible for
the observed reductions in diastolic BP. Although we do not
have data to support or refute this hypothesis, other
mechanisms could be considered, such as a decrease in
systemic vascular resistance, improvement in peripheral
sympathetic activity, and activation of the renin-angiotensin
system.
The strengths of this study include the large sample size,
randomized allocation, and blinding. In addition, contrary to all
previous studies, the CG was submitted to a sham interven-
tion, minimizing the potential inﬂuence of the frequent
contact with researchers and the placebo effect of the
training. The limitations include the heterogeneity of the
sample, which presented with different comorbidities and
Table 4. Intention-to-Treat Analysis of the Effect of IHT in Cardiovascular Parameters in Peripheral Artery Disease Patients
Control Group (n=52) IHT (n=50)
Interaction Effectn Pre Post n Pre Post
BP
Brachial systolic BP, mm Hg 52 149 (3) 146 (3) 50 143 (3) 141 (3) 0.915
Brachial diastolic BP, mm Hg 52 75 (2) 74 (2) 50 74 (1) 72 (1) 0.284
Central systolic BP, mm Hg 51 137 (3) 135 (3) 47 133 (3) 130 (3) 0.735
Central diastolic BP, mm Hg 51 75 (2) 76 (2) 47 75 (1) 73 (1) 0.377
Heart rate variability
SDNN, ms 49 38.2 (4.2) 36.5 (4.4) 44 34.6 (3.3) 40.9 (5.5) 0.348
RMSSD, ms 49 34.7 (5.3) 38.4 (8.5) 44 27.1 (3.3) 37.6 (8.1) 0.553
pNN50, % 49 9.6 (2.1) 9.1 (2) 44 7.5 (2.2) 9.3 (2.3) 0.138
Low frequency, ms2 49 470 (125) 1089 (203) 44 449 (113) 453 (66) 0.269
High frequency, ms2 49 825 (338) 1520 (298) 44 310 (80) 598 (124) 0.743
LF/HF 49 1.64 (0.30) 2.16 (0.48) 44 2.21 (0.30) 2.55 (0.54) 0.227
SD1, ms* 49 24.6 (3.7) 27.2 (6.0) 44 19.2 (2.3) 26.6 (5.7) 0.557
SD2, ms* 49 46.6 (5.0) 47.4 (5.2) 44 43.9 (4.1) 49.9 (5.2) 0.397
Shannon entropy* 49 3.3 (0.1) 3.2 (0.6) 44 3.2 (0.1) 3.2 (0.1) 0.684
Sample entropy* 49 1.4 (0.1) 1.4 (0.1) 44 1.4 (0.1) 1.4 (0.1) 0.997
Vascular mechanisms
Pulse pressure, mm Hg* 51 64 (3) 60 (3) 47 58 (2) 58 (3) 0.115
Augmentation index, % 51 38 (1) 35 (1) 47 36 (2) 36 (2) 0.052
Pulse wave velocity, m/s 41 9.6 (0.5) 9.1 (0.4) 43 9.9 (0.5) 9.7 (0.4) 0.970
Brachial diameter, mm 34 3.95 (0.10) 4.05 (0.10) 36 4.01 (0.15) 4.17 (0.15) 0.517
Flow-mediated dilation, % 33 7.69 (0.97) 7.53 (0.89) 35 5.90 (1.13) 9.21 (1.15) 0.057
Time to maximum diameter, s 33 78 (8) 94 (7) 35 67 (9) 90 (8) 0.713
AUC shear rate91001* 32 199 (19) 197 (17) 34 195 (25) 175 (28) 0.352
Blood flow, mL/min 34 66 (5) 74 (7) 36 76 (7) 70 (10) 0.138
FMD/AUC 32 0.05 (0.01) 0.05 (0.01) 34 0.04 (0.01) 0.07 (0.01) 0.069
Data presented as mean (SE). AUC indicates area under the curve of shear rate; BP, blood pressure; FMD/AUC, ﬂow-mediated dilation corrected by area under the curve of shear rate; IHT,
isometric handgrip group; LF/HF, low frequency/high frequency ratio; n, number of data for each variable analyzed; pNN50, percentage of number of pairs of adjacent NN intervals
differing by more than 50 ms; RMMSD, root mean square of the squared differences between adjacent normal RR intervals; SDNN, standard deviation of all RR intervals.
*Non parametric data presented as median (interquartile range).
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medication dose and use. However, this heterogeneity is
representative of the clinical spectrum of patients with PAD.
Although we veriﬁed medication use, preintervention and
postintervention, we cannot guarantee that the correct use of
drugs was used across the entire study duration. During the
study, we encountered technical difﬁculties with the ultra-
sound equipment, and thus ﬂow-mediated dilation was not
measured in all patients at both time points. Additionally, we
were unable to collect pulse wave velocity in some patients
because of the presence of arrhythmias and the lack of a
quantiﬁable femoral pulse. There was no standardization of
the time of day that the IHT was performed, which may have
generated different cardiovascular responses.35 Oxidative
stress and inﬂammation markers were not measured, and
the understanding of the mechanisms systemic of BP lowering
after isometric handgrip training was limited.
In conclusion, IHT reduced brachial diastolic BP and
improved local vascular function in patients with PAD. From
a clinical perspective, our 8-week program of IHT could provide
a simple, home-based, adjunct strategy to reduce brachial
diastolic BP in this clinical population. We note, however, that
this training stimulus was insufﬁcient to improve brachial
systolic BP, central BP, cardiac autonomic modulation, and
arterial stiffness parameters in patients with PAD.
Sources of Funding
This work was supported by grants from “Fundac~ao de Amparo
a Pesquisa do Estado de S~ao Paulo – FAPESP” (process#2016/
16425-9), “Conselho Nacional de Desenvolvimento Cientıﬁco e
Tecnologico–CNPQ” (process# 310508/2017-7), and “Coor-





1. Farah BQ, Ritti-Dias RM, Cucato GG, Chehuen Mda R, Barbosa JP, Zeratti AE,
Wolosker N, Puech-Leao P. Effects of clustered comorbid conditions on
walking capacity in patients with peripheral artery disease. Ann Vasc Surg.
2014;28:279–283.
2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell
K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S,
Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J,
Clement D, Creager M, Jaff M, Mohler E III, Rutherford RB, Sheehan P,
Sillesen H, Rosenﬁeld K. Inter-society consensus for the management of
peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33
(suppl 1):S1–S75.
3. Weitz JI, Byrne J, Clagett GP, Farkouh ME, Porter JM, Sackett DL,
Strandness DE Jr, Taylor LM. Diagnosis and treatment of chronic arterial
insufﬁciency of the lower extremities: a critical review. Circulation.
1996;94:3026–3049.
4. Ritti-Dias RM, Correia MA, Andrade-Lima A, Cucato GG. Exercise as a
therapeutic approach to improve blood pressure in patients with peripheral
arterial disease: current literature and future directions. Expert Rev Cardiovasc
Ther. 2018;17:65–73.
5. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, Collet JP,
Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai
L, Naylor AR, Rofﬁ M, Rother J, Sprynger M, Tendera M, Tepe G, Venermo M,
Vlachopoulos C, Desormais I; ESC Scientiﬁc Document Group. 2017 ESC
guidelines on the diagnosis and treatment of peripheral arterial diseases, in
collaboration with the european society for vascular surgery (ESVS): document
covering atherosclerotic disease of extracranial carotid and vertebral, mesen-
teric, renal, upper and lower extremity arteriesendorsed by: The European Stroke
Organization (ESO) the task force for the diagnosis and treatment of peripheral
arterial diseases of the European Society of Cardiology (ESC) and of the
European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.
6. Chehuen M, Cucato GG, Carvalho CR, Ritti-Dias RM, Wolosker N, Leicht AS,
Forjaz CL. Walking training at the heart rate of pain threshold improves
cardiovascular function and autonomic regulation in intermittent claudication:
a randomized controlled trial. J Sci Med Sport. 2017;20:886–892.
7. Grizzo Cucato G, de Moraes Forjaz CL, Kanegusuku H, da Rocha Chehuen M,
Riani Costa LA, Wolosker N, Kalil Filho R, de Fatima Nunes Marucci M, Mendes
Ritti-Dias R. Effects of walking and strength training on resting and exercise
cardiovascular responses in patients with intermittent claudication. Vasa.
2011;40:390–397.
8. Barbosa JP, Farah BQ, Chehuen M, Cucato GG, Farias Junior JC, Wolosker N,
Forjaz CL, Gardner AW, Ritti-Dias RM. Barriers to physical activity in patients
with intermittent claudication. Int J Behav Med. 2015;22:70–76.
9. Silva ATD, Fermino RC, Lopes AADS, Alberico CO, Reis RS. Distance to ﬁtness
zone, use of facilities and physical activity in adults. Rev Bras Med Esporte.
2018;24:157–161.
10. Treat-Jacobson D, McDermott MM, Bronas UG, Campia U, Collins TC, Criqui MH,
Gardner AW, Hiatt WR, Regensteiner JG, Rich K; American Heart Association
Council on Peripheral Vascular Disease; Council on Quality of Care and
Outcomes Research; andCouncil onCardiovascular and StrokeNursing. Optimal
exercise programs for patients with peripheral artery disease: a scientiﬁc
statement from the american heart association.Circulation. 2019;139:e10–e33.
11. Carlson DJ, Dieberg G, Hess NC, Millar PJ, Smart NA. Isometric exercise
training for blood pressure management: a systematic review and meta-
analysis. Mayo Clin Proc. 2014;89:327–334.
12. Inder JD, Carlson DJ, Dieberg G, McFarlane JR, Hess NC, Smart NA. Isometric
exercise training for blood pressure management: a systematic review and
meta-analysis to optimize beneﬁt. Hypertension Res. 2016;39:88–94.
13. Cornelissen VA, Smart NA. Exercise training for blood pressure: A systematic
review and meta-analysis. J Am Heart Assoc. 2013;2:e004473. DOI: 10.1161/
JAHA.112.004473.
14. Jin YZ, Yan S, Yuan WX. Effect of isometric handgrip training on resting blood
pressure in adults: a meta-analysis of randomized controlled trials. J Sports
Med Phys Fitness. 2017;57:154–160.
15. Farah BQ, Germano-Soares AH, Rodrigues SLC, Santos CX, Barbosa SS,
Vianna LC, Cornelissen VA, Ritti-Dias RM. Acute and chronic effects of
isometric handgrip exercise on cardiovascular variables in hypertensive
patients: a systematic review. Sports (Basel). 2017;5:E55.
16. Millar PJ, Levy AS, McGowan CL, McCartney N, MacDonald MJ. Isometric
handgrip training lowers blood pressure and increases heart rate complexity in
medicated hypertensive patients. Scand J Med Sci Sports. 2013;23:620–626.
17. Taylor AC, McCartney N, Kamath MV, Wiley RL. Isometric training lowers
resting blood pressure and modulates autonomic control. Med Sci Sports
Exerc. 2003;35:251–256.
18. Cahu Rodrigues SL, Farah BQ, Silva G, Correia M, Pedrosa R, Vianna L, Ritti-
Dias RM. Vascular effects of isometric handgrip training in hypertensives. Clin
Exp Hypertens. 2019. Published online January 9. DOI: 10.1080/10641963.
2018.1557683.
19. Badrov MB, Freeman SR, Zokvic MA, Millar PJ, McGowan CL. Isometric
exercise training lowers resting blood pressure and improves local brachial
artery ﬂow-mediated dilation equally in men and women. Eur J Appl Physiol.
2016;116:1289–1296.
20. McGowan CL, Visocchi A, Faulkner M, Verduyn R, Rakobowchuk M, Levy AS,
McCartney N, MacDonald MJ. Isometric handgrip training improves local ﬂow-
mediated dilation in medicated hypertensives. Eur J Appl Physiol.
2007;99:227–234.
21. Teixeira AL, Ritti-Dias R, Antonino D, Bottaro M, Millar PJ, Vianna LC. Sex
differences in cardiac baroreﬂex sensitivity following isometric handgrip
exercise. Med Sci Sports Exerc. 2018;50:770–777.
22. Farah BQ, Rodrigues SLC, Silva GO, Pedrosa RP, Correia MA, Barros MVG,
Deminice R, Marinello PC, Smart NA, Vianna LC, Ritti-Dias RM. Supervised, but
not home-based, isometric training improves brachial and central blood
pressure in medicated hypertensive patients: a randomized controlled trial.
Front Physiol. 2018;9:961.
23. Farah BQ, Vianna LC, Rodrigues SLC, Correia MA, Teixeira AL, Andrade FMDD,
Pedrosa RP, Moreira SR, Barros MVG, Wolosker N, Cucato GG, Ritti-Dias RM.
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 11


















 http://ahajournals.org by on February 26, 2020
Effects of isometric handgrip training in patients with cardiovascular disease:
rationale and design of the ISOPRESS network. Motriz. 2017;23:e101719.
24. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG; Consolidated Standards of Reporting Trials
Group. CONSORT 2010 Explanation and Elaboration: Updated guidelines for
reporting parallel group randomised trials. J Clin Epidemiol 2010;63:e1–e37.
25. Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes
FG, Hiatt WR, Jonsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande
RL, Preux PM, Stoffers HE, Treat-Jacobson D. Measurement and interpretation
of the ankle-brachial index: a scientiﬁc statement from the American Heart
Association. Circulation. 2012;126:2890–2909.
26. Sociedade Brasileira de Cardiologia; Sociedade Brasileira de Hipertens~ao;
Sociedade Brasileira de Nefrologia. [vi brazilian guidelines on hypertension].
Arq Bras Cardiol. 2010;95:1–51.
27. Siebenhofer A, Kemp C, Sutton A, Williams B. The reproducibility of central
aortic blood pressure measurements in healthy subjects using applanation
tonometry and sphygmocardiography. J Hum Hypertens. 1999;13:625–629.
28. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C,
Cockcroft J, Kaiser DR, Thuillez C. Clinical applications of arterial stiffness,
task force III: recommendations for user procedures. Am J Hypertens.
2002;15:445–452.
29. Heart rate variability: standards of measurement, physiological interpretation
and clinical use. Task Force of the European Society of Cardiology and the
North American Society of Pacing and Electrophysiology. Circulation.
1996;93:1043–1065.
30. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B,
Widlansky ME, Tschakovsky ME, Green DJ. Assessment of ﬂow-mediated
dilation in humans: a methodological and physiological guideline. Am J Physiol
Heart Circ Physiol. 2011;300:H2–H12.
31. Gomes APF, Correia MA, Soares AHG, Cucato GG, Lima A, Cavalcante BR,
Sobral-Filho DC, Ritti-Dias RM. Effects of resistance training on cardiovascular
function in patients with peripheral artery disease: a randomized controlled
trial. J Strength Cond Res. 2018;32:1072–1080.
32. Goernig M, Schroeder R, Roth T, Truebner S, Palutke I, Figulla HR, Leder U,
Voss A. Peripheral arterial disease alters heart rate variability in cardiovascular
patients. Pacing Clin Electrophysiol. 2008;31:858–862.
33. Lima AH, Soares AH, Cucato GG, Leicht AS, Franco FG, Wolosker N, Ritti-Dias
RM. Walking capacity is positively related with heart rate variability in
symptomatic peripheral artery disease. Eur J Vasc Endovasc Surg.
2016;52:82–89.
34. Husmann M, Jacomella V, Thalhammer C, Amann-Vesti BR. Markers of arterial
stiffness in peripheral arterial disease. Vasa. 2015;44:341–348.
35. Brito LC, Pecanha T, Fecchio RY, Rezende RA, Sousa P, DA Silva-Junior N,
Abreu A, Silva G, Mion-Junior D, Halliwill JR, Forjaz CLM. Morning versus
evening aerobic training effects on blood pressure in treated hypertension.
Med Sci Sports Exerc. 2019;51:653–662.
DOI: 10.1161/JAHA.119.013596 Journal of the American Heart Association 12


















 http://ahajournals.org by on February 26, 2020
